Two former Pfizer employees accused by the pharmaceutical giant of stealing trade secrets have filed a cross-claim in which they seek a declaration that they own the patent rights to a first-in-class oral medication to treat obesity and Type 2 diabetes.

The defendants, Min Zhong and Xiayang Qiu, worked at Pfizer’s facility in Groton and resigned in June 2018 after forming their own company, Regor Therapeutics. Pfizer filed a lawsuit against them on Feb. 2.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]